AACR 2023

April 14-19, 2023
Orlando, FL

American Association for Cancer Research

Explore more Hematology-Oncology congress materials

Results(1)

Hematology-Oncology

ERBB2 amplification detected in ctDNA as a surrogate for tumor tissue FISH analysis of HER2 status in a Phase 1 study with zanidatamab for the treatment of locally advanced or metastatic HER2 expressing cancers

Author(s): Diana Shpektor, Zymeworks, Inc.

Hematology-Oncology

View Poster

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.